EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incidence, Risk Factors and Outcomes of SARS‐CoV‐2 Infection in Pregnant Women: The COROPREG Population‐Based Study

Caroline Diguisto iD, Pierre-Yves Ancel, Aurélien Seco, Nathalie Baunot, Cecile Caze, Catherine Crenn-Hébert, Corinne Dupont, Charles Garabedian, Cécile Lebeaux, Camille Le Ray iD, Mathilde Letouzey, Elsa Lorthe iD und 6 weitere

Paediatric and Perinatal Epidemiology · 2025

DOI: 10.1111/ppe.70028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Paediatric and Perinatal Epidemiology, 2025. Verfasst von Caroline Diguisto und 17 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrical, Perinatal and Pediatric Life Course Epidemiology (OPPALE Team), Centre de Recherche Epidémiologie et StatistiqueS (CRESS), INSERM, INRAE…. Hauptthemen laut MEDLINE: COVID-19, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French ministry of Health, Programme Hospitalier de Recherche CliniqueCovid-19-20082.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Population‐based data are needed to reliably assess the impact of SARS‐CoV‐2 infection during pregnancy.

Objectives

To estimate the population‐based incidence of SARS‐CoV‐2 infection and its severe forms in the obstetric population, identify risk factors of severe SARS‐CoV‐2 infection (severe COVID‐19) and describe delivery, maternal and neonatal outcomes by disease severity, using a definition of severity based on organ dysfunction.

Methods

A prospective population‐based study conducted over the three first pandemic waves between March 2020 and April 2021 in 281 maternity hospitals in six French regions included all women with SARS‐CoV‐2 infection during pregnancy or within 7 days post‐partum, whether symptomatic or not, hospitalised or not. Severe COVID‐19 forms were defined a priori using clinical, biological and management criteria of organ dysfunction. We calculated infection and severe infection rates and studied associations between sociodemographic, medical and pregnancy characteristics and severe COVID‐19 by univariate and multivariate modified Poisson regression modelling.

Results

From a population of 385,214 deliveries in the participating regions, 6015 women with SARS‐CoV‐2 infection were identified, including 337 severe cases. The rates of severe COVID‐19 were 1.1, 0.9 and 3.6 per 1000 deliveries during the first, second and third pandemic waves, respectively, and the proportions of severe COVID‐19 were 8.6%, 3.4% and 9.3%, respectively. On multivariate analysis, the risk of severe COVID‐19 was associated with younger and older age, migrant status, living with > 4 people, overweight or obesity, chronic hypertension or diabetes and infection ≥ 22 weeks of gestation rather than earlier in pregnancy. Neonatal morbidity occurred mostly with severe maternal infection.

Conclusion

Using an organ‐based definition of severity and population‐based data, rates of severe COVID‐19 appeared lower than in previous studies. A permanent perinatal surveillance system is needed to assess efficiently and rapidly the impact of future pandemics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Pregnancy Complications, InfectiousHumansFemalePregnancyAdultRisk FactorsFranceIncidenceSARS-CoV-2Prospective StudiesPregnancy OutcomeInfant, NewbornSeverity of Illness IndexYoung Adult

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2maternal morbidityneonatal morbiditypregnancyrisk factors

Autor:innen und Institutionen

  • Obstetrical, Perinatal and Pediatric Life Course Epidemiology (OPPALE Team), Centre de Recherche Epidémiologie et StatistiqueS (CRESS), INSERM, INRAE, Université Paris Cité and Université Sorbonne Paris Nord, Paris, Fra…
  • Department of Obstetrics, Centre Hospitalier Régional Universitaire et Faculté de Médecine de Tours, Tours, France.
  • Clinical Investigation Center CIC P1419, Assistance Publique-Hôpitaux de Paris, GH Paris Centre, Université Paris Cité, Paris, France.
  • Clinical Research Unit Necker Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Réseau de Santé en Périnatalité Parisien, Paris, France.
  • Réseau de Santé en Périnatalité Naître dans l'Est Parisien, Paris, France.

ORCID-Profile: Caroline Diguisto, Camille Le Ray, Elsa Lorthe, Catherine Deneux-Tharaux

Förderung

  • French ministry of Health, Programme Hospitalier de Recherche CliniqueCovid-19-20082

Zitieren

APA

Diguisto, C., Ancel, P. Y., Seco, A., Baunot, N., Caze, C., Crenn-Hébert, C., Dupont, C., Garabedian, C., Lebeaux, C., Le Ray, C., Letouzey, M., Lorthe, E., Marrer, E., Rouger, V., Vayssière, C., Vauloup Fellous, C., Bonnet, M. P., & Deneux-Tharaux, C. (2025). Incidence, Risk Factors and Outcomes of SARS‐CoV‐2 Infection in Pregnant Women: The COROPREG Population‐Based Study. Paediatric and Perinatal Epidemiology. https://doi.org/10.1111/ppe.70028

Vancouver

Diguisto C, Ancel PY, Seco A, Baunot N, Caze C, Crenn-Hébert C, et al. Incidence, Risk Factors and Outcomes of SARS‐CoV‐2 Infection in Pregnant Women: The COROPREG Population‐Based Study. Paediatric and Perinatal Epidemiology. 2025. doi:10.1111/ppe.70028

BibTeX
@article{Diguisto2025,
  author = {Diguisto, Caroline and Ancel, Pierre-Yves and Seco, Aurélien and Baunot, Nathalie and Caze, Cecile and Crenn-Hébert, Catherine and Dupont, Corinne and Garabedian, Charles and Lebeaux, Cécile and Le Ray, Camille and Letouzey, Mathilde and Lorthe, Elsa and Marrer, Emilie and Rouger, Valérie and Vayssière, Christophe and Vauloup Fellous, Christelle and Bonnet, Marie-Pierre and Deneux-Tharaux, Catherine},
  title = {Incidence, Risk Factors and Outcomes of SARS‐CoV‐2 Infection in Pregnant Women: The COROPREG Population‐Based Study},
  journal = {Paediatric and Perinatal Epidemiology},
  year = {2025},
  doi = {10.1111/ppe.70028}
}
Kostenlos starten →